Sunshine Biopharma (SBFM) Short-term Investments (2019 - 2025)

Sunshine Biopharma has reported Short-term Investments for 5 years, with the latest figure at $70457.0 in Q1 2025.

• For the quarter ending Q1 2025, Short-term Investments changed N/A year-over-year to $70457.0; the trailing twelve-month figure through Mar 2025 stood at $70457.0 (changed N/A YoY), and the FY2021 full-year result was $7590.0, changed 0.0% from the prior year.
• Short-term Investments for Q1 2025 stood at $70457.0, up from $7590.0 in the prior quarter.
• The five-year high for Short-term Investments was $70457.0 in Q1 2025, with the low at $7590.0 in Q1 2021.
• Historically, Short-term Investments has averaged $15448.4 across 3 years, with a median of $7590.0 in 2021.
• The largest YoY upside for Short-term Investments was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
• Sunshine Biopharma's Short-term Investments stood at $7590.0 in 2021, then changed by 0.0% to $7590.0 in 2022, then jumped by 828.29% to $70457.0 in 2025.
• The last three Short-term Investments figures came in at $70457.0 (Q1 2025), $7590.0 (Q3 2022), and $7590.0 (Q2 2022), per Business Quant data.